These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35797675)

  • 1. Delayed-Onset Inflammatory Optic Nerve Sheath Mass and Perineuritis Following Cessation of Ipilimumab and Nivolumab Therapy.
    Kamboj A; Hwang CJ; McClelland CM; Maltry AC; Harrison AR; Mokhtarzadeh A
    Ophthalmic Plast Reconstr Surg; 2022 Jul-Aug 01; 38(4):e119-e122. PubMed ID: 35797675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune polyradiculitis due to combination immunotherapy with ipilimumab and nivolumab for the treatment of metastatic melanoma.
    Lasocki A; Smith K
    J Clin Neurosci; 2020 Apr; 74():240-241. PubMed ID: 31983645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report.
    Miyauchi Y; Naito H; Tsunemori H; Tani R; Hasui Y; Miyake Y; Minamino T; Ishikawa R; Kushida Y; Haba R; Sugimoto M
    J Med Case Rep; 2021 Oct; 15(1):508. PubMed ID: 34649593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune Bell's Palsy Following Immunotherapy For Metastatic Melanoma: A Report of 2 Cases.
    Zieman D; Frankel AE
    J Immunother; 2019 Oct; 42(8):318-320. PubMed ID: 31318723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A Case of Metachronous Occurrence of Interstitial Pneumonitis and Hypophysitis Following Nivolumab Plus Ipilimumab for Metastatic Renal Cell Carcinoma].
    Hayase T; Washino S; Mayumi S; Yazaki K; Nakamura Y; Oshima M; Konishi T; Saito K; Miyagawa T
    Hinyokika Kiyo; 2021 Jun; 67(6):239-243. PubMed ID: 34265899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapy.
    Tan I; Malinzak M; Salama AKS
    J Immunother Cancer; 2018 Jul; 6(1):77. PubMed ID: 30064495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival Outcomes Following Discontinuation of Ipilimumab and Nivolumab for Advanced Melanoma in a Population-based Cohort.
    Ksienski D; Truong PT; Wai ES; Croteau NS; Chan A; Patterson T; Clarkson M; Hackett S; Irons S; Lesperance M
    Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):e561-e569. PubMed ID: 34226113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral Hypotony Maculopathy Associated With Ipilimumab and Nivolumab Therapy Unresponsive to Corticosteroid Treatment.
    Ahmed AA; Hiya FE; Eichenbaum DA
    Ophthalmic Surg Lasers Imaging Retina; 2023 May; 54(5):301-304. PubMed ID: 37078857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral Acute Optic Perineuritis Associated With COVID-19 in a Patient With Seronegative Myelin Oligodendrocyte Glycoprotein (MOG) Antibody.
    Ali L; Naeem M; Canibano B; John A; Iqrar A
    Cureus; 2021 Sep; 13(9):e18234. PubMed ID: 34712522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of immune-related adverse events in metastatic renal cell carcinoma treated with nivolumab plus ipilimumab.
    Ikeda T; Ishihara H; Nemoto Y; Tachibana H; Fukuda H; Yoshida K; Takagi T; Iizuka J; Hashimoto Y; Ishida H; Kondo T; Tanabe K
    Urol Oncol; 2021 Oct; 39(10):735.e9-735.e16. PubMed ID: 34172370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Widespread subacute cutaneous lupus erythematosus in a patient receiving checkpoint inhibitor immunotherapy with ipilimumab and nivolumab.
    Kosche C; Owen JL; Choi JN
    Dermatol Online J; 2019 Oct; 25(10):. PubMed ID: 31735010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: Thrombotic-Thrombocytopenic Purpura Following Ipilimumab and Nivolumab Combination Immunotherapy for Metastatic Melanoma.
    Mullally WJ; Cooke FJ; Crosbie IM; Kumar S; Abernethy VE; Jordan EJ; O'Connor M; Horgan AM; Landers R; Naidoo J; Calvert PM
    Front Immunol; 2022; 13():871217. PubMed ID: 35514990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report.
    Appelbaum J; Wells D; Hiatt JB; Steinbach G; Stewart FM; Thomas H; Nghiem P; Kapur RP; Thompson JA; Bhatia S
    J Immunother Cancer; 2018 Aug; 6(1):82. PubMed ID: 30170630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial granulomatous dermatitis and concurrent immunotherapy associated encephalitis with nivolumab and ipilimumab.
    Starling CT; Messer AA; Kleiman A; McQuade JL; Glitza IC; Torres-Cabala CA; Heberton M
    Dermatol Online J; 2022 Mar; 28(2):. PubMed ID: 35670686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response.
    Baettig F; Vlajnic T; Vetter M; Glatz K; Hench J; Frank S; Bihl M; Lopez R; Dobbie M; Heinzelmann-Schwarz V; Montavon C
    J Immunother Cancer; 2019 Oct; 7(1):281. PubMed ID: 31672171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ophthalmic Immune-Related Adverse Events of Immunotherapy: A Single-Site Case Series.
    Kim JM; Materin MA; Sznol M; Kluger HM; Weiss S; Chow J; Stoessel K; Kombo N; Del Priore L; Pointdujour-Lim R
    Ophthalmology; 2019 Jul; 126(7):1058-1062. PubMed ID: 30735682
    [No Abstract]   [Full Text] [Related]  

  • 17. Optic Perineuritis Associated with Nivolumab Treatment for Non-Small Cell Lung Cancer.
    Takada K; Fujiwara K; Ando E; Onishi K; Kuribayashi T; Mitsumune S; Takigawa Y; Matsuura H; Watanabe H; Kudo K; Sato A; Sato K; Shibayama T
    Case Rep Oncol; 2021; 14(2):792-796. PubMed ID: 34248541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report.
    Hultin S; Nahar K; Menzies AM; Long GV; Fernando SL; Atkinson V; Cebon J; Wong MG
    BMC Nephrol; 2020 Sep; 21(1):391. PubMed ID: 32894101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panuveitis in patient on ipilimumab/nivolumab combination for small-cell lung cancer treated with an intravitreal dexamethasone implant.
    L Hefler J; M Bailey L; El Rahi C; C Schefler A; Bernicker EH
    J Oncol Pharm Pract; 2021 Jul; 27(5):1261-1264. PubMed ID: 33108990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers: Subgroup Analysis of a Phase 2 Nonrandomized Clinical Trial.
    Klein O; Kee D; Nagrial A; Markman B; Underhill C; Michael M; Jackett L; Lum C; Behren A; Palmer J; Tebbutt NC; Carlino MS; Cebon J
    JAMA Oncol; 2020 Sep; 6(9):1405-1409. PubMed ID: 32729929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.